IMA Advisory Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
PI
IMA Advisory Services's JAZZ Position: Q2 2019 in Review
IMA Advisory Services sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2019, closing a stake of 5 shares — an estimated $1K sold.
IMA Advisory Services first reported a position in JAZZ in Q2 2018 and held it in 4 quarters. The position peaked at $1K in Q1 2019. 416 funds tracked by Wall St. Rank hold JAZZ as of Q2 2019.
- IMA Advisory Services reported no remaining Jazz Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
- IMA Advisory Services sold 5 Jazz Pharmaceuticals shares in Q2 2019, an estimated $1K.
- IMA Advisory Services first reported a position in Jazz Pharmaceuticals in Q2 2018 and held it in 4 quarters.
- IMA Advisory Services's Jazz Pharmaceuticals position peaked at $1K in Q1 2019.
- 416 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2019.
Based on IMA Advisory Services's 13F filing for Q2 2019, filed 19 Jul 2019.